rs367645097
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_000260.4(MYO7A):c.3925-8G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000568 in 1,610,458 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000260.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO7A | NM_000260.4 | c.3925-8G>A | splice_region_variant, intron_variant | ENST00000409709.9 | NP_000251.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.3925-8G>A | splice_region_variant, intron_variant | 1 | NM_000260.4 | ENSP00000386331.3 | ||||
MYO7A | ENST00000458637.6 | c.3925-8G>A | splice_region_variant, intron_variant | 1 | ENSP00000392185.2 | |||||
MYO7A | ENST00000409619.6 | c.3892-8G>A | splice_region_variant, intron_variant | 1 | ENSP00000386635.2 | |||||
MYO7A | ENST00000458169.2 | c.1468-8G>A | splice_region_variant, intron_variant | 1 | ENSP00000417017.2 | |||||
MYO7A | ENST00000670577.1 | n.1765-8G>A | splice_region_variant, intron_variant | ENSP00000499323.1 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152156Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000333 AC: 81AN: 243588Hom.: 0 AF XY: 0.000347 AC XY: 46AN XY: 132636
GnomAD4 exome AF: 0.000599 AC: 873AN: 1458302Hom.: 1 Cov.: 31 AF XY: 0.000590 AC XY: 428AN XY: 725268
GnomAD4 genome AF: 0.000276 AC: 42AN: 152156Hom.: 0 Cov.: 33 AF XY: 0.000323 AC XY: 24AN XY: 74336
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 30, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Autosomal recessive nonsyndromic hearing loss 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Autosomal dominant nonsyndromic hearing loss 11 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Usher syndrome type 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 05, 2013 | 3925-8G>A in Intron 30 of MYO7A: This variant is not expected to have clinical significance because it was shown to have no effect on splicing in an ex-vivo fu nctional study (Le Guedard-Mereuze 2010) and it is not located in the invariant -1/-2 positions of the splice site consensus sequence. The variant has been iden tified in 0.02% (2/8402) of European American chromosomes by the NHLBI Exome seq uencing project (http://evs.gs.washington.edu/EVS/) and in an individual with Us her type I syndrome but the authors reported it as a neutral variant (Le Guedard -Mereuze 2010). - |
MYO7A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 13, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at